Method for inhibiting onset of or treating pollen allergy
AssigneeNatura, Inc.
InventorsMasafumi Koide, Ryutaro Tsuda, Kenji Fujisawa
Life of this patent
Estimating the term…
Abstract
The intermolecular mutual recognition between a disease-state inducing substance (e.g., allergen group, pathogen et cetera) and a living body which functions at the time when such a disease-state inducing substance reaches the living body is inhibited by making use of pectins and nucleic acids.
Claims15
A method for inhibiting onset of or treating pollen allergy reactions in a person having pollen allergy comprising administering to said person an effective amount of a preparation, wherein the preparation comprises a uronic acid-containing polysaccharide and a negatively charged macromolecular DNA.
A method for inhibiting onset of or treating eye itching or nose itching in a person having pollen allergy, comprising administering to said person an effective amount of a preparation comprising a uronic acid-containing polysaccharide and a negatively charged macromolecular DNA.
A method for inhibiting pollen allergens from binding to cell surface acceptors of a person having pollen allergy, comprising administering to said person an effective amount of a preparation, wherein the preparation comprises a uronic acid-containing polysaccharide and a negatively charged macromolecular DNA.
Dependencies are inferred from the claim text.